300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Digital Media
Retail
Oil and Gas
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Sports
Legal
Wellness
Automotive
Education
eSports
Biotechnology
Renewable Energy
Facebook
Software
Blockchain
Theatre
Medical
Beauty
Web3
Recruiting
Fashion
Celebrity
Infrastructure
Cannabis
Social
LGBT
Climate
Food and Beverage
Real Estate
Life Science
Sporting Goods
Music
Publishing
Art
Finance
Manufacturing
FinTech
Social Media
Wine and Spirits
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Mobile Apps
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Oman
Zimbabwe
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Estonia
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Iceland
Cambodia
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Heidi Kakko, Angel Investor at European Innovation Council

Heidi Kakko

Angel Investor @ European Innovation Council

Heidi Kakko is a Series A investor at European Innovation Council focused on Medical and Health Care. Heidi Kakko leads the Development Fund´s investment division by preparing the investments and developing the whole market.Heidi has been actively participating in financing and acquiring companies since 1995, she worked on business consultation and finance at the world`s biggest consultation company PricewaterhouseCoopers for more than 10years.Before joining the Development Fund, Heidi worked as an M&A Leader at an international investment company East Partners, focusing on the markets of Ukraine, Russia and Georgia. As an executive manager, Heidi has gained experience working at the biggest BTL agency in the Baltics as well as developing one of the first Estonian training companies into a business school.

Total investments:
5
Last investment:
Lead investor:
60%

Last updated:

Industries Heidi Kakko invests in

MedicalHealth CareTherapeuticsBiotechnologyManufacturing

Stages Heidi Kakko invests in

Series AFunding RoundSeed

Countries Heidi Kakko invests in

NorwayEstoniaIrelandSwitzerland

Round sizes

Series A $1.8M–$16M

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$1.8M–$16M

Investment Focus

Industry

  • Medical 1 (20%)
  • Health Care 1 (20%)
  • Therapeutics 1 (20%)
  • Biotechnology 1 (20%)
  • Manufacturing 1 (20%)
See all 7 industries →

Stage

  • Series A 2 (40%)
  • Funding Round 2 (40%)
  • Seed 1 (20%)

Country

  • Norway 1 (20%)
  • Estonia 1 (20%)
  • Ireland 1 (20%)
  • Switzerland 1 (20%)

Investments

CompanyDescriptionRoundLinks
Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing.Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds(https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing. $1.8M / Venture - Series Unknown / Jun 09, 2026
Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing.Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds(https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing. $402.7K / Seed / Jan 10, 2023
Sensibel commercializes ultra-high-sensitivity MEMS microphones based on an optical MEMS technology. $16.1M / Series A / Apr 25, 2022
Positrigo is a company dedicated to the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. $1.8M / Series A / Jul 30, 2021
RemedyBio is an immunology-focused discovery and development company based in Dublin, Ireland. It has pioneered a new approach to understanding the immune system and the discovery of new therapies. $9.4M / Venture - Series Unknown / Jul 20, 2021

Co-Investors

European Innovation Council

About European Innovation Council

VC Fund · Brussels, Belgium

The European Innovation Council aims to support top-class innovators, entrepreneurs, small companies, and researchers with bright ideas. The EIC co-invests alongside private investors in early-stage startups that have ESG impacts.

European Innovation Council Contacts

NameEmailPhoneSocials
Baybars Altuntas
Baybars Altuntas Board Member
Candace Johnson
Candace Johnson President
Jacopo Losso
Jacopo Losso Director of Secretariat
Pablo Hernández
Pablo Hernández IT Expert
Selma Prodanovic
Selma Prodanovic Board Member & Vice President

Sign up to unlock verified contacts

Unlock Contacts

See all 21 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Digital Media
Retail
Oil and Gas
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Sports
Legal
Wellness
Automotive
Education
eSports
Biotechnology
Renewable Energy
Facebook
Software
Blockchain
Theatre
Medical
Beauty
Web3
Recruiting
Fashion
Celebrity
Infrastructure
Cannabis
Social
LGBT
Climate
Food and Beverage
Real Estate
Life Science
Sporting Goods
Music
Publishing
Art
Finance
Manufacturing
FinTech
Social Media
Wine and Spirits
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Mobile Apps
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Oman
Zimbabwe
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Estonia
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Iceland
Cambodia
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Heidi Kakko invest in?

Heidi Kakko invests primarily in Medical, Health Care and Therapeutics startups, most often at Series A and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Heidi Kakko invest in?

Heidi Kakko typically joins rounds of $1.8M–$16M at Series A. These are whole funding-round sizes, not Heidi Kakko's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Heidi Kakko took part in.

How do I contact Heidi Kakko?

Public channels for Heidi Kakko include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Heidi Kakko last invest?

The most recent investment recorded for Heidi Kakko closed in Jun 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Heidi Kakko Heidi Kakko Find email